Bridging Latin American software with global life sciences: biotech, pharma & health
Latin America has world-class software talent.
Life sciences — biotech, pharma, and health — is booming and well-funded.
Yet these two worlds rarely connect.
Puente Bio is here to build that bridge.
- Enter three high-growth industries with solid funding.
- Stand out as a pioneer in software for life sciences.
- Build solutions with global impact on health and quality of life.
What do we do at Puente Bio?
We help Latin American software companies:
Adapt their capabilities to biotech, pharma, and health needs.
Design tailored solutions (AI, LIMS, dashboards, clinical trials, EHRs, telemedicine).
Connect with international clients across the life sciences ecosystem.
Our Consultancy Products
Workshop Puente Bio - 6 meetings
1. Introduction
The biotech, health, and pharma industries are experiencing accelerated growth at both global and regional levels, creating a demand for innovative digital solutions that integrate data, artificial intelligence, and clinical processes. From Puente BIO, we propose a tailored program designed for software factories seeking to explore and validate new business lines focused on this sector.
2. Program Objective
To guide the software factory through six practical and strategic sessions in order to:
- Understand the biotech/health/pharma market and its opportunities.
- Design and validate a new business line or digital product.
- Incorporate bioinformatics as a strategic differentiator.
- Define an implementation roadmap and a clear go-to-market strategy.
3. Program Structure (6 sessions, 2 hours each)
Session 1: Introduction & Opportunities in Biotech
Overview of the biotech and health landscape. Introduction to bioinformatics as a field for developers.
Session 2: Understanding the Client & Opportunity Detection
Mapping the biotech client journey. Identifying bioinformatics needs within the industry.
Session 3: Solution Ideation
Generating digital solution ideas. Integrating bioinformatics as added value.
Session 4: Validation & Business Model
Competitive benchmarking. Rapid validation. Value proposition and business model design. Should you create an internal bioinformatics unit?
Session 5: Roadmap & Go-to-Market
MVP roadmap design. Strategies to train or attract bioinformaticians. Initial commercialization.
Session 6: Final Presentation & Feedback
Pitch of the new business line or product, highlighting differentiation through bioinformatics. Feedback panel with experts.
4. Expected Outcomes
- Identification of a concrete niche within biotech/health/pharma.
- Design of a viable digital solution for that niche.
- Definition of value proposition, business model, and MVP roadmap.
- Initial go-to-market strategy.
- Strategy for incorporating bioinformaticians into the software factory.
5. Investment
To be defined according to the number of participants per company.
(Includes six sessions, working materials, facilitation, and feedback from guest experts.)
6. Why Puente BIO
- →Proven experience bridging the tech and biotech worlds.
- →Practical methodology with tangible deliverables in every session.
- →Network of contacts across biotech, health, and pharma in Latin America.
- →A distinctive focus on bioinformatics as a strategic bridge.
Martin Larre CEO
Martin Larre - Founder and CEO
Biotech, Tech & AI Innovation entrepreneur
Founder Future Biome & Puente Bio
Building ecosystems where science meets business and leaders grow with purpose.
Contact Us
Interested in working together? Book a meeting or send me an email. We can't wait to hear from you.